Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Double-blind, placebo-controlled phase 3 study of memantine in obsessive-compulsive disorder
2009-016751-22Phase 3Active
- Sponsor
- Amsterdam University Medical Center
- Start
- Oct 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in obsessive compulsive disorder (OCD) comparing Memantine with Placebo (2 arms). Primary endpoint: Change in Y-BOCS from baseline to week 12. Started Oct 2009; status: active.
02
Drugs
memantine
03
Conditions
obsessive compulsive disorder (OCD)
Beyond the preview
Go deeper on 2009-016751-22.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-016751-22.